They account for nearly 83% of all cells in the human body, yet red blood cells are often portrayed as little more than bags of hemoglobin ferrying oxygen from the lungs to the heart and beyond.

Across the country, kids are settling into new school year routines. Parents buy backpacks, teachers arrange desks and lesson plans, and friends reconnect.

When public health researchers want to know whether diseases such as COVID-19 or polio are circulating in a community, they can look for genetic evidence in wastewater.

​About 1.2 million people in the United States are living with HIV, or human immunodeficiency virus. Because of major advances in medical treatment and technology, people with HIV are living long, healthy lives.

A study initiated by a University of Arizona Cancer Center physician-scientist Dr. Dan Theodorescu revealed that the loss of the Y chromosome in men's body tissue could pave the way for cancer to develop in that tissue.

In the sickest COVID-19 patients, the SARS-CoV-2 virus doesn't just cause severe damage by directly infecting airway cells.

Researchers have uncovered a previously unknown gene causing resistance to a leading blood cancer drug and several genes that accelerate lymphoma growth by using a powerful new CRISPR activation library.

A team of researchers trained three machine learning models-Logistic Regression, Random Forest, and Support Vector Machine (SVM)-to classify healthcare workers according to their level of psychosocial resilience, using information collected during the COVID-19 pandemic.

ITM Isotope Technologies Munich SE and Telix Pharmaceuticals, two leading companies in the burgeoning radiopharmaceuticals field, are merging.

HUNTINGTON BEACH, Calif. — Rheumatologists should exercise caution in interpreting clinical trial results, with a particular awareness of potential errors and confounders, said a presenter at the Congress of Clinical Rheumatology West.
“Think critically when interpreting trial results and be careful not to over-interpret the delta between the active and placebo arms,” Andreas Kerschbaumer, MD, PhD, a postdoctoral scholar in the division of immunology and rheumatology at Stanford University, told Healio in an interview. “Study design, where a trial recruited, and